Medtronic plc (NYSE: MDT) today announced the start of the Embrace Gynecology investigational device exemption (IDE) U.S.

With positive trial results in urology and hernia repair already under its belt, the company is getting closer to taking on ...

Embrace Gynecology becomes the third IDE clinical study for Hugo RAS in the U.S., demonstrating Medtronic’s commitment to ...

Medtronic has initiated the Embrace Gynecology study in the US to assess the Hugo robotic-assisted surgery (RAS) system's ...

Companies creating new robotic platforms marked additional milestones heading into the fourth quarter. Catch up with their ...

Medtronic (NYSE: MDT) announced today that it began the Embrace Gynecology  U.S. clinical study of its Hugo surgical robotic ...

Nearly 60 of the state’s biggest companies showcased their latest innovations, historical artifacts or community impact ...

Surgical robotics is not a new phenomenon, but it's a space that continues to foster innovation across a range of ...

Belgium's AZ Maria Middelares is proud to take on a pioneering role as a technology-driven health care organization.

The next-generation intervention cardiology sector is experiencing a transformative shift, leveraging precision-guided, ...

In an era of rapid medical advancement, the Powered Surgical Instrument Market is witnessing steady expansion, driven by ...

Southeast Asia Surgical Robotics Market was valued at USD 256.15 million in 2024 and is expected to grow at a strong CAGR of ...